組換えタンパク質の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、宿主細胞別、地域別、セグメント別予測、2025年～2030年

組換えタンパク質市場の成長と動向

組換えタンパク質の世界市場規模は、2030年には55億8,000万米ドルに達すると予想され、2025～2030年にかけてCAGR 10.2%で成長すると予測されています。

多発性硬化症、好中球減少症、脳溢血、貧血などの疾患や小人症が一般的になりつつあり、組換えタンパク質医薬品の需要を押し上げています。さらに、生物製剤の開発・研究の活発化により、産業の拡大が予想され、それが世界の産業の成長を大きく後押ししています。バイオシミラー、生物製剤、組換えタンパク質の開発への注目は、がんの罹患率や有病率の上昇、研究開発活動の拡大により高まっています。

米国がん協会によると、2022年には新たに190万人のがん患者が発生し、60万9,360人ががん関連で死亡すると予想されています。さらに、ELISA、ウェスタンブロット、免疫組織化学（IHC）などの臨床診断法における組換えタンパク質の応用拡大が、市場拡大に拍車をかけると予想されています。研究開発費の増加、がん患者数の増加、新規治療やテーラーメイド治療への要望などの要因から、予測期間中に世界の産業は大幅に拡大すると予想されます。COVID-19の大流行を受けて、ウイルスの動態を理解するために組換えタンパク質セグメントの調査活動が活発化しています。組換えタンパク質の生産は、オーダーメイド治療とともに大幅に増加しています。

さらに、組換え蛋白質、特にCOVID-19に関連した免疫応答蛋白質に対する需要と生産の増加とともに、研究資金がより容易に利用できるようになると予測されています。そのため、COVID-19に特化した製品を提供する企業にはプラスの効果が見られています。組換えタンパク質は、タンパク質の生産量を向上させ、有用な商業製品を作り、遺伝子配列を変更するために、多くの方法で生産することができる天然タンパク質の改良版と見なされています。世界産業の主要原動力は、製薬企業の研究開発費の増加、慢性疾患の高い発生率、規制要件の増加、ウイルス感染を減らす継続的な必要性です。

予測期間中、世界産業は組換えタンパク質の合成における技術的進歩によって牽引されると予想されます。例えば、2022年6月、National Center for BIoTechnology Informationが作成したデータによると、CRISPR/Cas9、TALEN、ジンクフィンガーを介するような新たな育種技術や、トランスジェニックまたはシスジェニック技術は、承認される遺伝子のin vitro遺伝子編集または操作を容易にする可能性のある新たな技術です。さらに、人口の高齢化、所得水準の上昇、より良い医療インフラ、医療費の増加、新興国における低コスト製造の利点から、市場参入企業はこの地域に投資し、市場成長を促進すると予想されます。

組換えタンパク質市場レポートハイライト

• サイトカインと成長因子セグメントは、2024年に市場で24.6%の最大シェアを占めました。このセグメントは予測期間を通じて飛躍的な成長が見込まれます。
• 治療セグメントは、代謝異常、がん、遺伝病、免疫疾患など様々な疾患の蔓延により、2024年に34.2%のシェアで世界市場を独占しました。
• 製薬・バイオテクノロジー企業セグメントは、2024年に38.1％の最大市場シェアを獲得しました。生物製剤とバイオシミラーへの傾倒は、バイオメーカーによる、製品パイプラインの拡大、新技術の考案、バイオプロセシングツールの進歩のための研究開発への数100万米ドル規模の投資の連鎖をもたらしました。
• 2024年の組換え蛋白質市場では、哺乳類セグメントが42.1％の最大売上シェアを占めました。
• 北米は、慢性疾患の発生率の増加、最先端の治療法の使用、主要企業の存在、同地域における医療支出の増加により、2024年に支配的な地域となりました。

目次

第1章 組み換えタンパク質市場：調査手法と範囲

第2章 組み換えタンパク質市場：エグゼクティブサマリー

• 市場展望
• セグメントスナップショット
• 競合情勢のスナップショット

第3章 組み換えタンパク質市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場動向と展望
  • 市場力学
  • 市場抑制要因分析
• ビジネス環境分析
  • PESTEL分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析

第4章 製品ビジネス分析

• 製品セグメントダッシュボード
• 組み換えタンパク質市場：製品変動分析
• 世界の組み換えタンパク質市場規模と動向分析、製品別、2018～2030年
• サイトカインと成長因子
  • サイトカインと成長因子市場、2018～2030年
  • インターフェロン（IFN）
  • インターロイキン（IL）
  • その他
• 抗体
  • 抗体、2018～2030年
• 免疫チェックポイントタンパク質
  • 免疫チェックポイントタンパク質市場、2018～2030年
• ウイルス抗原
  • ウイルス抗原市場、2018～2030年
• 酵素
  • 酵素市場、2018～2030年
  • キナーゼ
  • 代謝酵素
  • その他
• 組み換え調節タンパク質
  • 組み換え調節タンパク質市場、2018～2030年
• ホルモン
  • ホルモン市場、2018～2030年
• その他
  • その他市場、2018～2030年

第5章 宿主細胞ビジネス分析

• 宿主細胞セグメントダッシュボード
• 組み換えタンパク質市場：宿主細胞変動分析
• 世界の組換えタンパク質市場規模と動向分析、宿主細胞別、2018～2030年
• 哺乳類細胞
  • 哺乳類細胞市場、2018～2030年
• 細菌細胞
  • 細菌細胞市場、2018～2030年
• 酵母と菌類
  • 酵母と菌類の市場、2018～2030年
• 昆虫細胞
  • 昆虫細胞市場、2018～2030年
• その他
  • その他市場、2018～2030年

第6章 用途ビジネス分析

• 用途セグメントダッシュボード
• 組み換えタンパク質市場：用途変動分析
• 世界の組み換えタンパク質市場規模と動向分析、用途別、2018～2030年
• 医薬品の発見と開発
  • 医薬品の発見と開発市場、2018～2030年
• 治療
  • 生物製剤
  • ワクチン
  • 細胞・遺伝子治療
  • その他
• 研究
  • 研究市場、2018～2030年
• その他
  • その他市場、2018～2030年

第7章 最終用途ビジネス分析

• 最終用途セグメントダッシュボード
• 組み換えタンパク質市場：最終用途変動分析
• 世界の組み換えタンパク質市場規模と動向分析、最終用途別、2018～2030年
• 製薬・バイオテクノロジー企業
  • 製薬・バイオテクノロジー企業市場、2018～2030年
• 学術研究機関
  • 学術研究機関市場、2018～2030年
• その他
  • その他市場、2018～2030年

第8章 地域ビジネス分析

• 地域ダッシュボード
• 地域別の世界の市場シェア、2024年と2030年
• 北米
  • 北米の組み換えタンパク質市場、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 欧州の組み換えタンパク質市場、2018～2030年
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋の組み換えタンパク質市場、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • タイ
  • オーストラリア
• ラテンアメリカ
  • ラテンアメリカ組み換えタンパク質市場、2018～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ組み換えタンパク質市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific, Inc.
  • Sino Biological, Inc.
  • GenScript
  • Bio-Techne
  • Proteintech Group, Inc.
  • Enzo Life Sciences, Inc.
  • Abnova Corp
  • RayBIoTech Life Inc.
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 5 Global Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 6 Global Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 7 Global Recombinant Protein Market, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 10 North America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 11 North America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 12 North America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 13 U.S. Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 14 U.S. Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 15 U.S. Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 16 U.S. Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 17 Canada Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 18 Canada Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 19 Canada Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 20 Canada Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 21 Mexico Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 22 Mexico Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 23 Mexico Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 24 Mexico Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 25 Europe Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
• Table 26 Europe Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 27 Europe Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 28 Europe Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 29 Europe Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 30 Germany Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 31 Germany Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 32 Germany Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 33 Germany Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 34 UK Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 35 UK Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 36 UK Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 37 UK Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 38 France Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 39 France Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 40 France Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 41 France Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 42 Italy Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 43 Italy Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 44 Italy Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 45 Italy Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 46 Spain Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 47 Spain Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 48 Spain Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 49 Spain Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 50 Denmark Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 51 Denmark Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 52 Denmark Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 53 Denmark Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 54 Sweden Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 55 Sweden Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 56 Sweden Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 57 Sweden Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 58 Norway Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 59 Norway Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 60 Norway Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 61 Norway Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million
• Table 62 Asia Pacific Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 67 China Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 68 China Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 69 China Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 70 China Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 71 Japan Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 72 Japan Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 73 Japan Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 74 Japan Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 75 India Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 76 India Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 77 India Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 78 India Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 79 South Korea Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 80 South Korea Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 81 South Korea Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 82 South Korea Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 83 Australia Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 84 Australia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 85 Australia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 86 Australia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 87 Thailand Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 88 Thailand Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 89 Thailand Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 90 Thailand Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 91 Latin America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
• Table 92 Latin America Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 93 Latin America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 94 Latin America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 95 Latin America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 96 Brazil Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 97 Brazil Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 98 Brazil Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 99 Brazil Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 100 Argentina Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 101 Argentina Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 102 Argentina Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 103 Argentina Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 109 South Africa Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 110 South Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 111 South Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 112 South Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 117 UAE Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 118 UAE Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 119 UAE Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 120 UAE Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 121 Kuwait Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
• Table 122 Kuwait Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
• Table 123 Kuwait Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
• Table 124 Kuwait Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
• Table 125 Participant's Overview
• Table 126 Financial Performance
• Table 127 Key Companies Undergoing Expansions
• Table 128 Key Companies Undergoing Acquisitions
• Table 129 Key Companies Undergoing Collaborations
• Table 130 Key Companies Launching New Products/Services
• Table 131 Key Companies Undergoing Partnerships
• Table 132 Key Companies Undertaking Other Strategies

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Recombinant Protein, Market Segmentation
• Fig. 8 Market Snapshot, 2024
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis
• Fig. 11 Market Restraint Relevance Analysis (Porter's Five Forces Analysis
• Fig. 12 Global Recombinant Protein Market: Product Movement Analysis
• Fig. 13 Global Recombinant Protein Market, for Product, 2018 - 2030 (USD Million)
• Fig. 14 Global Recombinant Protein Market: Application Movement Analysis
• Fig. 15 Global Recombinant Protein Market, for Drug Discovery & Development, 2018 - 2030 (USD Million)
• Fig. 16 Global Recombinant Protein Market, for Therapeutics, 2018 - 2030 (USD Million)
• Fig. 17 Global Recombinant Protein Market, for Research , 2018 - 2030 (USD Million)
• Fig. 18 Global Recombinant Protein Market, for Others, 2018 - 2030 (USD Million)
• Fig. 19 Global Recombinant Protein Market: End Use Movement Analysis
• Fig. 20 Global Recombinant Protein Market, for Pharma & Biotechnology Companies, 2018 - 2030 (USD Million)
• Fig. 21 Global Recombinant Protein Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
• Fig. 22 Global Recombinant Protein Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
• Fig. 23 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
• Fig. 24 Global Recombinant Protein Market: Host Cell Movement Analysis
• Fig. 25 Global Recombinant Protein Market, for Mammalian systems, 2018 - 2030 (USD Million)
• Fig. 26 Global Recombinant Protein Market, for Insect Cells, 2018 - 2030 (USD Million)
• Fig. 27 Global Recombinant Protein Market, for Yeast & Fungi, 2018 - 2030 (USD Million)
• Fig. 28 Global Recombinant Protein Market, for Bacterial Cells, 2018 - 2030 (USD Million)
• Fig. 29 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
• Fig. 30 Regional Marketplace: Key Takeaways
• Fig. 31 Regional Outlook, 2024 & 2030
• Fig. 32 Global Recombinant Protein Market: Region Movement Analysis
• Fig. 33 North America Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 34 US Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 35 Canada Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 36 Mexico Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 37 Europe Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 38 Germany Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 39 UK Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 40 France Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 41 Italy Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 42 Spain Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 43 Denmark Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 44 Sweden Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 45 Norway Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 46 Asia Pacific Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 47 Japan Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 48 China Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 49 India Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 50 Australia Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 51 South Korea Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 52 Thailand Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 53 Latin America Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 54 Brazil Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 55 Argentina Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 56 Middle East and Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 57 South Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 58 Saudi Arabia Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 59 UAE Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 60 Kuwait Recombinant Protein Market, 2018 - 2030 (USD Million)
• Fig. 61 Market participant categorization
• Fig. 62 Recombinant Proteins Market Position Analysis, 2024
• Fig. 63 Strategy framework

Recombinant Proteins Market Growth & Trends:

The global recombinant proteins market size is expected to reach USD 5.58 billion in 2030 and is projected to grow at a CAGR of 10.2% from 2025 to 2030. Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth. The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of cancer and the expansion of research & development activity.

According to the American Cancer Society, in 2022, there will be 1.9 million new cancer cases and 609,360 cancer-related deaths. In addition, the expanding application of recombinant proteins in clinical diagnostic methods including ELISA, Western Blotting, and Immunohistochemistry (IHC) is anticipated to fuel market expansion. Due to factors including rising R&D spending, an increase in the number of cancer patients, and the desire for novel & tailored therapies, the global industry is anticipated to expand significantly during the forecast period. Research activity in recombinant protein space has increased in response to the COVID-19 pandemic as a result of efforts to comprehend the dynamics of the virus. The production of recombinant proteins has increased significantly, along with tailored treatment.

In addition, research funding is predicted to become more readily available along with an increase in demand for and production of recombinant proteins, particularly those immune response proteins associated with COVID-19. Therefore, positive effects have been seen for the companies offering products specifically made for COVID-19. Recombinant protein is viewed as a modified version of natural protein that can be produced in a number of ways to improve protein output, create useful commercial goods, and alter gene sequences. The main drivers of the global industry are the rise in pharmaceutical firms' R&D expenditures, high incidence of chronic illnesses, an increase in the number of regulatory requirements, and the ongoing need to reduce viral infections.

Over the projected period, the global industry is anticipated to be driven by technological advancements in the synthesis of recombinant proteins. For instance, in June 2022, according to the data produced by the National Center for Biotechnology Information, new breeding techniques, such as CRISPR/Cas9, TALEN, and Zinc Finger mediated, as well as transgenic or cis-genic techniques, are emerging technologies that may make it easier for in vitro genetic editing or manipulation of the genes to be approved. In addition, industry participants are anticipated to invest in the region due to the aging population, rising income levels, better healthcare infrastructure, rising healthcare spending, and the advantages of low-cost manufacturing in developing nations, thereby propelling market growth.

Recombinant Proteins Market Report Highlights:

• The cytokines & growth factors segment held the largest share of 24.6% of the market in 2024. This segment is anticipated to grow exponentially throughout the forecast period.
• The therapeutics segment dominated the global market with a share of 34.2% in 2024 due to the prevalence of various diseases, such as metabolic disorders, cancer, genetic disorders, and immune diseases.
• The pharma & biotechnology companies segment captured the largest market share of 38.1% in 2024. The inclination towards biologics and biosimilars has resulted in a cascade of multi-million investments by bio-manufacturers in R&D to grow the pipeline of products, devise new technologies, and advance bioprocessing tools.
• The mammalian segment held the largest revenue share of 42.1% of the recombinant proteins market in 2024.
• North America was the dominant region in 2024 due to an increase in the incidence of chronic diseases, use of cutting-edge treatments, the presence of key players, and a rise in healthcare spending in the region.

Table of Contents

Chapter 1. Recombinant Proteins Market: Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Host Cell Segment
  • 1.2.3. Application Segment
  • 1.2.4. End-use Segment
• 1.3. Research Assumptions
• 1.4. Information Procurement
  • 1.4.1. Primary Research
• 1.5. Information or Data Analysis
• 1.6. Market Formulation & Validation
• 1.7. Market Model
• 1.8. Global Market: CAGR Calculation
• 1.9. Objectives

Chapter 2. Recombinant Proteins Market: Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Recombinant Proteins Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
  • 3.2.1. Market Dynamics
    • 3.2.1.1. Increasing Investments In Research & Development Activities
    • 3.2.1.2. Growing research activities for drug discovery and precision medicine
    • 3.2.1.3. Rising adoption of biologics & biosimilars
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Regulatory and safety concerns regarding protein production
    • 3.2.2.2. Dearth of skilled personnel and expertise
• 3.3. Business Environment Analysis
  • 3.3.1. PESTEL Analysis
  • 3.3.2. Porter's Five Forces Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Recombinant Proteins Market: Product Movement Analysis
• 4.3. Global Recombinant Proteins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Cytokines & Growth Factors
  • 4.4.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
  • 4.4.2. Interferons (IFNs)
    • 4.4.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
  • 4.4.3. Interleukins (ILs)
    • 4.4.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others Market, 2018 - 2030 (USD Million)
• 4.5. Antibodies
  • 4.5.1. Antibodies, 2018 - 2030 (USD Million)
• 4.6. Immune Checkpoint Proteins
  • 4.6.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
• 4.7. Virus Antigens
  • 4.7.1. Virus Antigens Market, 2018 - 2030 (USD Million)
• 4.8. Enzymes
  • 4.8.1. Enzymes Market, 2018 - 2030 (USD Million)
  • 4.8.2. Kinases
    • 4.8.2.1. Kinases Market, 2018 - 2030 (USD Million)
  • 4.8.3. Metabolic Enzymes
    • 4.8.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
  • 4.8.4. Others
    • 4.8.4.1. Others Market, 2018 - 2030 (USD Million)
• 4.9. Recombinant Regulatory Proteins
  • 4.9.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
• 4.10. Hormones
  • 4.10.1. Hormones Market, 2018 - 2030 (USD Million)
• 4.11. Others
  • 4.11.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Host Cell Business Analysis

• 5.1. Host Cell Segment Dashboard
• 5.2. Recombinant Proteins Market: Host Cell Movement Analysis
• 5.3. Global Recombinant Proteins Market Size & Trend Analysis, by Host Cell, 2018 to 2030 (USD Million)
• 5.4. Mammalian Cells
  • 5.4.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
• 5.5. Bacterial Cells
  • 5.5.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
• 5.6. Yeast & Fungi
  • 5.6.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
• 5.7. Insect Cells
  • 5.7.1. Insect Cells Market, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Recombinant Proteins Market: Application Movement Analysis
• 6.3. Global Recombinant Proteins Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Drug Discovery & Development
  • 6.4.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
• 6.5. Therapeutics
  • 6.5.1. Biologics
    • 6.5.1.1. Biologics Market, 2018 - 2030 (USD Million)
  • 6.5.2. Vaccines
    • 6.5.2.1. Vaccines Market, 2018 - 2030 (USD Million)
  • 6.5.3. Cell & Gene Therapies
    • 6.5.3.1. Cell & Gene Therapies Market, 2018 - 2030 (USD Million)
  • 6.5.4. Others
    • 6.5.4.1. Others Market, 2018 - 2030 (USD Million)
• 6.6. Research
  • 6.6.1. Research Market, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Recombinant Proteins Market: End-use Movement Analysis
• 7.3. Global Recombinant Proteins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• 7.5. Academic & Research Institutes
  • 7.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Regional Dashboard
• 8.2. Global Market Share By Region, 2024 & 2030
• 8.3. North America
  • 8.3.1. North America Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Scenario
    • 8.3.2.4. U.S. Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Scenario
    • 8.3.3.4. Canada Recombinant Proteins Market, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Scenario
    • 8.4.2.4. UK Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Scenario
    • 8.4.3.4. Germany Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4.4. Spain
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Scenario
    • 8.4.4.4. Spain Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4.5. France
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Scenario
    • 8.4.5.4. France Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4.6. Italy
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Scenario
    • 8.4.6.4. Italy Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Scenario
    • 8.4.7.4. Denmark Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Scenario
    • 8.4.8.4. Sweden Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Scenario
    • 8.4.9.4. Norway Recombinant Proteins Market, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia-Pacific Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Scenario
    • 8.5.2.4. Japan Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Scenario
    • 8.5.3.4. China Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Scenario
    • 8.5.4.4. India Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Scenario
    • 8.5.5.4. South Korea Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Scenario
    • 8.5.6.4. Thailand Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5.7. Australia
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Scenario
    • 8.5.7.4. Australia Recombinant Proteins Market, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Scenario
    • 8.6.2.4. Brazil Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.6.3. Mexico
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Scenario
    • 8.6.3.4. Mexico Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.6.4. Argentina
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Scenario
    • 8.6.4.4. Argentina Recombinant Proteins Market, 2018 - 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Scenario
    • 8.7.2.4. South Africa Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Scenario
    • 8.7.3.4. Saudi Arabia Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Scenario
    • 8.7.4.4. UAE Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Scenario
    • 8.7.5.4. Kuwait Recombinant Proteins Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific, Inc.
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Sino Biological, Inc.
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Product Benchmarking
    • 9.4.2.3. Strategic Initiatives
  • 9.4.3. GenScript
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Bio-Techne
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Proteintech Group, Inc.
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Product Benchmarking
    • 9.4.5.3. Strategic Initiatives
  • 9.4.6. Enzo Life Sciences, Inc.
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Product Benchmarking
    • 9.4.6.3. Strategic Initiatives
  • 9.4.7. Abnova Corp
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Product Benchmarking
    • 9.4.7.3. Strategic Initiatives
  • 9.4.8. RayBiotech Life Inc.
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Product Benchmarking
    • 9.4.8.3. Strategic Initiatives
  • 9.4.9. STEMCELL Technologies Inc.
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Product Benchmarking
    • 9.4.9.3. Strategic Initiatives
  • 9.4.10. Bio-Rad Laboratories, Inc.
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Product Benchmarking
    • 9.4.10.3. Strategic Initiatives
  • 9.4.11. Merck KGaA
    • 9.4.11.1. Company Overview
    • 9.4.11.2. Product Benchmarking
    • 9.4.11.3. Strategic Initiatives